Genmab A (GMAB) EBIT Margin (2018 - 2026)
Genmab A (GMAB) posted EBIT Margin of 20.09% for Q1 2026, down 46.89% on a QoQ basis from 37.83% in Q3 2025, and down 620.0% year-over-year from 3.86% in Q1 2025.
Genmab A (GMAB) EBIT Margin (2018 - 2026) Analysis & Trends
Genmab A's EBIT Margin history runs 6 years deep, the most recent figure standing at 20.09% for Q1 2026.
- Quarterly EBIT Margin fell 620.0% year-over-year to 20.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 32.52% (down 1891.0% YoY) and the FY2025 annual result came in at 28.63%, down 251.0% from the prior year.
- EBIT Margin was 20.09% for Q1 2026 at Genmab A, down from 37.83% in the prior quarter.
- Across five years, EBIT Margin topped out at 37.83% in Q3 2025 and bottomed at 19.24% in Q1 2024.
- A 3-year average of 27.49% and a median of 26.29% in 2025 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2025 — EBIT Margin surged 794 bps — and 2026, when it plunged 620 bps.
- Genmab A's EBIT Margin stood at 30.12% in 2024, then advanced by 26 bps to 37.83% in 2025, then slumped by 47 bps to 20.09% in 2026.
- Business Quant data shows GMAB's EBIT Margin at 20.09% in Q1 2026, 37.83% in Q3 2025, and 33.41% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | 20.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.09% |
| Sep 30, 2025 | 37.83% |
| Jun 30, 2025 | 33.41% |
| Mar 31, 2025 | 26.29% |
| Sep 30, 2024 | 30.12% |
| Jun 30, 2024 | 25.47% |
| Mar 31, 2024 | 19.24% |
| Sep 30, 2020 | 99.53% |
| Dec 31, 2019 | 165.56% |
| Sep 30, 2019 | 66,269,919,334,153.95% |
| Dec 31, 2018 | 166.56% |